98%
921
2 minutes
20
Purpose: To report a 72-year-old man with orbital metastasis as presenting symptoms from a prostatic adenocarcinoma.
Methods: A complete ophthalmological evaluation with ultrasonography examination, kinetic perimetry, fluorescein angiography, and visually evoked potentials were performed. The patient underwent computed tomography, magnetic resonance imaging of the orbit, and blood test for confirmation of the diagnosis. Bone infiltration rate of the cancer was evaluated with bone scintigraphy. Type of the tumor was assessed with orbital incision biopsy and histological analysis. The patient received systemic chemotherapy. Due to poor patient compliance, radiotherapy was not performed.
Results: Ultrasonography showed a hypoechoic retrobulbar lesion. At computed tomography examination of the orbit an expansive oval intraconical solid lesion with enhancement after medium contrast was found. Biopsy findings revealed a moderately differentiated adenocarcinoma with immunohistochemical profile supporting prostate as the primary tumor site: negative for cytokeratin-7 and cytokeratin-20 and positive for prostate-specific antigen, prostate-specific acid phosphatase, and alpha-methylacyl-CoA-racemase.
Conclusions: Ocular signs and symptoms as first clinical presentation of a prostate cancer are relatively rare. Despite its very poor prognosis, a correct management and therapy can improve visual acuity, ocular symptoms, and median survival of cancer patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/1120672119832182 | DOI Listing |
Life (Basel)
July 2025
Department of Radiation Oncology, Keimyung University School of Medicine, Daegu 42601, Republic of Korea.
We present a rare case of delayed retrobulbar and adrenal metastases from renal cell carcinoma (RCC), diagnosed 5.5 years after radical nephrectomy. The patient exhibited symptomatic orbital involvement, with imaging revealing a hypervascular retrobulbar mass and an incidental right adrenal lesion, indicative of an oligometastatic state.
View Article and Find Full Text PDFCureus
July 2025
Pathology and Laboratory Medicine, Hospital Clínico Universitario, Valladolid, ESP.
Primary mucinous adenocarcinoma of the orbit is an exceptionally rare epithelial malignancy that closely mimics metastatic disease both clinically and radiologically, often delaying definitive diagnosis. We report the case of a 69-year-old man who presented with progressive ocular pain, axial proptosis, and a well-circumscribed orbital mass on imaging. Histopathological evaluation following incisional biopsy revealed a mucinous adenocarcinoma with signet ring morphology.
View Article and Find Full Text PDFBr J Ophthalmol
August 2025
Department of Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Purpose: To evaluate the presenting symptoms, and the overall survival (OS) and disease-specific survival (DSS) in patients with lacrimal gland adenoid cystic carcinoma (LGACC).
Methods: This retrospective single-centre cohort study included all consecutive patients with LGACC treated by the primary author from November 1998 through August 2024. Demographic data, presenting symptoms, the histological subtype of LGACC, type of surgical treatment, adjuvant radiotherapy or chemotherapy, T category at presentation and survival data were reviewed.
Orbital metastasis is a rare manifestation of systemic malignancy, accounting for approximately 2%-5% of orbital tumours. The most common primary cancers associated with orbital metastases include breast carcinoma, malignant melanoma and prostate carcinoma. Hepatocellular carcinoma (HCC) is an uncommon source of all reported orbital metastases.
View Article and Find Full Text PDFJ Am Soc Cytopathol
July 2025
Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. Electronic address:
Introduction: Leptomeningeal metastasis is a rare and poor prognostic factor in patients with solid malignancies. Cerebrospinal fluid (CSF) cytology is a reliable method for diagnosing CSF metastasis. This study aims to evaluate the reliability of CSF cytology for detection and subclassification of CSF metastasis and to report the different types of solid malignant CSF metastasis at our institution.
View Article and Find Full Text PDF